We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Gemcitabine-induced supraventricular tachycardia: A rare manifestation.
- Authors
Abraham, Linu Jacob; Rudresha, A. H.; Saldanha, Smitha Carol; Koppaka, Deepak; Kuntegowdanahalli, Lakshmaiah Chinnagiriyappa; Dasappa, Lokanatha; Kiran, Pretesh Rohan
- Abstract
Gemcitabine is a cytotoxic drug with superior toxicity profile and widely used in the management of various solid malignancies. The common side effects associated with gemcitabine are myelosuppression, diarrhea, and flu-like symptoms. Cardiac side effects due to gemcitabine are very rare. We present a case of an elderly female aged 69 years, diagnosed to have metastatic carcinoma gallbladder, and without any cardiac risk factors, who developed supraventricular tachycardia 3 days after gemcitabine infusion. We emphasize the need for careful and routine cardiac monitoring in an elderly patient who develops symptoms of tachyarrhythmia when on gemcitabine therapy.
- Subjects
ANTINEOPLASTIC agents; SUPRAVENTRICULAR tachycardia; DRUG toxicity; MYELOSUPPRESSION; GALLBLADDER cancer; TACHYARRHYTHMIAS
- Publication
Clinical Cancer Investigation Journal, 2016, Vol 5, Issue 2, p200
- ISSN
2278-1668
- Publication type
Article
- DOI
10.4103/2278-0513.178064